lenalidomide has been researched along with delanzomib in 2 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (delanzomib) | Trials (delanzomib) | Recent Studies (post-2010) (delanzomib) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 37 | 1 | 31 |
| Protein | Taxonomy | lenalidomide (IC50) | delanzomib (IC50) |
|---|---|---|---|
| Neutrophil elastase | Homo sapiens (human) | 3.55 | |
| Cathepsin G | Homo sapiens (human) | 1.0618 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 3.5 | |
| Proteasome subunit beta type-1 | Homo sapiens (human) | 0.031 | |
| Chymase | Homo sapiens (human) | 3.53 | |
| Proteasome subunit beta type-8 | Homo sapiens (human) | 0.003 | |
| Proteasome subunit beta type-9 | Homo sapiens (human) | 0.001 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 0.0033 | |
| Proteasome subunit beta type-10 | Homo sapiens (human) | 0.01 | |
| Proteasome subunit beta type-2 | Homo sapiens (human) | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appel, A | 1 |
| Berenson, JR; Chen, H; Hunter, K; Jones-Bolin, S; Li, J; Li, M; Ruggeri, B; Sanchez, E; Wang, C | 1 |
2 other study(ies) available for lenalidomide and delanzomib
| Article | Year |
|---|---|
Drugs: More shots on target.
Topics: Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Clinical Trials as Topic; Drug Resistance, Neoplasm; Glycine; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Oligopeptides; Protease Inhibitors; Pyrazines; Survival Rate; Thalidomide; Threonine | 2011 |
CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Cell Line, Tumor; Dexamethasone; Humans; Lenalidomide; Mice; Mice, SCID; Multiple Myeloma; Thalidomide; Threonine; Xenograft Model Antitumor Assays | 2012 |